Cargando…

Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination

Background: In order to develop a new screening test of cognitive impairment, we studied whether cognitive function can be estimated from basic blood test data by applying deep learning models. This model was constructed based on the effects of systemic metabolic disorders on cognitive function. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakatani, Kaoru, Oyama, Katsunori, Hu, Lizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769169/
https://www.ncbi.nlm.nih.gov/pubmed/33381075
http://dx.doi.org/10.3389/fneur.2020.588140
_version_ 1783629268216971264
author Sakatani, Kaoru
Oyama, Katsunori
Hu, Lizhen
author_facet Sakatani, Kaoru
Oyama, Katsunori
Hu, Lizhen
author_sort Sakatani, Kaoru
collection PubMed
description Background: In order to develop a new screening test of cognitive impairment, we studied whether cognitive function can be estimated from basic blood test data by applying deep learning models. This model was constructed based on the effects of systemic metabolic disorders on cognitive function. Methods: We employed a deep neural network (DNN) to predict cognitive function based on subject's age and blood test items (23 items). We included 202 patients (73.48 ± 13.1 years) with various systemic metabolic disorders for training of the DNN model, and the following groups for validation of the model: (1) Patient group, 65 patients (73.6 ± 11.0 years) who were hospitalized for rehabilitation after stroke; (2) Healthy group, 37 subjects (62.0 ± 8.6 years); (3) Health examination group, 165 subjects (54.0 ± 8.6 years) admitted for a health examination. The subjects underwent the Mini-Mental State Examination (MMSE). Results: There were significant positive correlations between the predicted MMSE scores and ground truth scores in the Patient and Healthy groups (r = 0.66, p < 0.001). There were no significant differences between the predicted MMSE scores and ground truth scores in the Patient group (p > 0.05); however, in the Healthy group, the predicted MMSE scores were slightly, but significantly, lower than the ground truth scores (p < 0.05). In the Health examination group, the DNN model classified 94 subjects as normal (MMSE = 27–30), 67 subjects as having mild cognitive impairment (24–26), and four subjects as having dementia (≤ 23). In 37 subjects in the Health examination group, the predicted MMSE scores were slightly lower than the ground truth MMSE (p < 0.05). In contrast, in the subjects with neurological disorders, such as subarachnoid hemorrhage, the ground truth MMSE scores were lower than the predicted scores. Conclusions: The DNN model could predict cognitive function accurately. The predicted MMSE scores were significantly lower than the ground truth scores in the Healthy and Health examination groups, while there was no significant difference in the Patient group. We suggest that the difference between the predicted and ground truth MMSE scores was caused by changes in atherosclerosis with aging, and that applying the DNN model to younger subjects may predict future cognitive impairment after the onset of atherosclerosis.
format Online
Article
Text
id pubmed-7769169
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77691692020-12-29 Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination Sakatani, Kaoru Oyama, Katsunori Hu, Lizhen Front Neurol Neurology Background: In order to develop a new screening test of cognitive impairment, we studied whether cognitive function can be estimated from basic blood test data by applying deep learning models. This model was constructed based on the effects of systemic metabolic disorders on cognitive function. Methods: We employed a deep neural network (DNN) to predict cognitive function based on subject's age and blood test items (23 items). We included 202 patients (73.48 ± 13.1 years) with various systemic metabolic disorders for training of the DNN model, and the following groups for validation of the model: (1) Patient group, 65 patients (73.6 ± 11.0 years) who were hospitalized for rehabilitation after stroke; (2) Healthy group, 37 subjects (62.0 ± 8.6 years); (3) Health examination group, 165 subjects (54.0 ± 8.6 years) admitted for a health examination. The subjects underwent the Mini-Mental State Examination (MMSE). Results: There were significant positive correlations between the predicted MMSE scores and ground truth scores in the Patient and Healthy groups (r = 0.66, p < 0.001). There were no significant differences between the predicted MMSE scores and ground truth scores in the Patient group (p > 0.05); however, in the Healthy group, the predicted MMSE scores were slightly, but significantly, lower than the ground truth scores (p < 0.05). In the Health examination group, the DNN model classified 94 subjects as normal (MMSE = 27–30), 67 subjects as having mild cognitive impairment (24–26), and four subjects as having dementia (≤ 23). In 37 subjects in the Health examination group, the predicted MMSE scores were slightly lower than the ground truth MMSE (p < 0.05). In contrast, in the subjects with neurological disorders, such as subarachnoid hemorrhage, the ground truth MMSE scores were lower than the predicted scores. Conclusions: The DNN model could predict cognitive function accurately. The predicted MMSE scores were significantly lower than the ground truth scores in the Healthy and Health examination groups, while there was no significant difference in the Patient group. We suggest that the difference between the predicted and ground truth MMSE scores was caused by changes in atherosclerosis with aging, and that applying the DNN model to younger subjects may predict future cognitive impairment after the onset of atherosclerosis. Frontiers Media S.A. 2020-12-14 /pmc/articles/PMC7769169/ /pubmed/33381075 http://dx.doi.org/10.3389/fneur.2020.588140 Text en Copyright © 2020 Sakatani, Oyama and Hu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Sakatani, Kaoru
Oyama, Katsunori
Hu, Lizhen
Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title_full Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title_fullStr Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title_full_unstemmed Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title_short Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination
title_sort deep learning-based screening test for cognitive impairment using basic blood test data for health examination
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769169/
https://www.ncbi.nlm.nih.gov/pubmed/33381075
http://dx.doi.org/10.3389/fneur.2020.588140
work_keys_str_mv AT sakatanikaoru deeplearningbasedscreeningtestforcognitiveimpairmentusingbasicbloodtestdataforhealthexamination
AT oyamakatsunori deeplearningbasedscreeningtestforcognitiveimpairmentusingbasicbloodtestdataforhealthexamination
AT hulizhen deeplearningbasedscreeningtestforcognitiveimpairmentusingbasicbloodtestdataforhealthexamination